Cargando…
The association between post-treatment surveillance testing and survival in stage II and III colon cancer patients: An observational comparative effectiveness study
BACKGROUND: The best strategy for surveillance testing in stage II and III colon cancer patients following curative treatment is unknown. Previous randomized controlled trials have suffered from design limitations and yielded conflicting evidence. This observational comparative effectiveness researc...
Autores principales: | Hines, Robert B., Jiban, Md Jibanul Haque, Specogna, Adrian V., Vishnubhotla, Priya, Lee, Eunkyung, Zhang, Shunpu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500008/ https://www.ncbi.nlm.nih.gov/pubmed/31053096 http://dx.doi.org/10.1186/s12885-019-5613-5 |
Ejemplares similares
-
Post-treatment surveillance testing of patients with colorectal cancer and the association with survival: protocol for a retrospective cohort study of the Surveillance, Epidemiology, and End Results (SEER)-Medicare database
por: Hines, Robert B, et al.
Publicado: (2018) -
Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
por: van den Broek, Evert, et al.
Publicado: (2016) -
Predictors of recurrence free survival for patients with stage II and III colon cancer
por: Tsikitis, Vassiliki L, et al.
Publicado: (2014) -
Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer
por: Shanmugam, Chandrakumar, et al.
Publicado: (2011) -
Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021)